U.S. markets close in 3 hours 52 minutes
  • S&P 500

    4,186.26
    -35.60 (-0.84%)
     
  • Dow 30

    33,445.49
    -377.96 (-1.12%)
     
  • Nasdaq

    14,072.80
    -88.55 (-0.63%)
     
  • Russell 2000

    2,258.11
    -29.35 (-1.28%)
     
  • Crude Oil

    71.96
    +0.92 (+1.30%)
     
  • Gold

    1,774.60
    -0.20 (-0.01%)
     
  • Silver

    26.09
    +0.23 (+0.91%)
     
  • EUR/USD

    1.1886
    -0.0024 (-0.20%)
     
  • 10-Yr Bond

    1.4580
    -0.0530 (-3.51%)
     
  • GBP/USD

    1.3816
    -0.0108 (-0.78%)
     
  • USD/JPY

    110.1980
    -0.0330 (-0.03%)
     
  • BTC-USD

    36,465.62
    -2,420.26 (-6.22%)
     
  • CMC Crypto 200

    898.29
    -41.66 (-4.43%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Why Is GlaxoSmithKline Selling Its Income Stream to Royalty Pharma?

·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Apparently, up-front capital is better than royalties on drugs the pharma doesn't have control over.